Form 8-K - Current report:
SEC Accession No. 0001213900-24-068942
Filing Date
2024-08-14
Accepted
2024-08-14 15:55:21
Documents
15
Period of Report
2024-08-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0211411-8k_60degrees.htm   iXBRL 8-K 30692
2 PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF AUGUST 12, 2024 ea021141101ex99-1_60degrees.htm EX-99.1 31144
  Complete submission text file 0001213900-24-068942.txt   291636

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sxtp-20240812.xsd EX-101.SCH 3792
4 XBRL DEFINITION FILE sxtp-20240812_def.xml EX-101.DEF 26654
5 XBRL LABEL FILE sxtp-20240812_lab.xml EX-101.LAB 36762
6 XBRL PRESENTATION FILE sxtp-20240812_pre.xml EX-101.PRE 25278
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0211411-8k_60degrees_htm.xml XML 5897
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 241207086
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)